A prospective open label study to evaluate vasomotor symptoms control and bleeding patterns with a continuous regimen of a new progestin trimegestone 0.125 mg and 17 b estradiol 1 mg (Totelle), as HT [hormone therapy] on postmenopausal women

Trial Profile

A prospective open label study to evaluate vasomotor symptoms control and bleeding patterns with a continuous regimen of a new progestin trimegestone 0.125 mg and 17 b estradiol 1 mg (Totelle), as HT [hormone therapy] on postmenopausal women

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2007

At a glance

  • Drugs Estradiol/trimegestone (Primary)
  • Indications Vasomotor symptoms
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 11 Dec 2007 Status changed from in progress to completed.
    • 23 Jul 2007 Status change
    • 31 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top